| 764168 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
553 First-in-class inhibitors of ERAP1 alter the immunopeptidome of cancer, driving a differentiated T cell response leading to tumor growth inhibition |
2021-11-01 |
10.1136/jitc-2021-sitc2021.553 |
Joyce Peter, Quibell Martin, Shiers Jason, Tong Carmen, Clark Kristopher, Ternette Nicola, Anderton Kate, Sette Jessica, Paes Wayne, Leishman Andrew |
| 764167 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
629 Evaluation of provider preferences in first-line metastatic renal cell carcinoma: comparison between dual immunotherapy vs. immunotherapy/tyrosine kinase inhibitors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.629 |
Chablani Priyanka, Karrison Theodore, Stadler Walter |
| 764166 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
337 Intratumoral immune therapy for recurrent breast cancer with polyICLC, and tremelimumab combined with systemic durvalumab |
2021-11-01 |
10.1136/jitc-2021-sitc2021.337 |
Slingluff Craig, Mauldin Ileana, Gaughan Elizabeth, Dillon Patrick, Opyrchal Mateusz, Puzanov Igor, Kruse Megan, Gastman Brian, Friedlander Philip, Marron Thomas, Aufiero Kristen, Macri Mary, Schwarzenberger Paul, Ricciardi Toni, Ryan Aileen, Venhaus Ralph, Saxena Mansi, Edmonds Nicole, Bhardwaj Nina |
| 764165 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
536 Intratumoral INT230–6 shows a favorable safety profile and early signs of efficacy in advanced soft tissue sarcoma with monotherapy and in combination with ipilimumab [Intensity IT-01; BMS#CA184–592] |
2021-11-01 |
10.1136/jitc-2021-sitc2021.536 |
Ingham Matthew, Hu James, Whalen Giles, Thomas Jacob, El-Khoueiry Anthony, Hanna Diana, Olszanski Anthony, Meyer Christian, Azad Nilofer, Mahmood Syed, Bender Lewis, Walters Ian, Siu Lilian, Razak Albiruni |
| 764164 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
920 A single-cell spatially resolved MERFISH map of the colorectal tumor immune microenvironment |
2021-11-01 |
10.1136/jitc-2021-sitc2021.920 |
Price Colles, Chen Jonathan, Pelka Karin, Chao Sherry, He Jiang, Boland Genevieve, Emanuel George, Hacohen Nir |
| 764163 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
919 Tegavivint reduces the immunosuppressive macrophage phenotype in a preclinical co-culture model of the non-small cell lung cancer tumor microenvironment |
2021-11-01 |
10.1136/jitc-2021-sitc2021.919 |
Chandra Raghav, Flaming Josiah, Nguyen Aiden, Peyton Michael, Das Amit, Gao Boning, Horrigan Steven, Brekken Rolf, Minna John |
| 764162 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
918 Doxycycline regulatable ß-catenin demonstrates inducible immune evasion in a melanoma GEM model |
2021-11-01 |
10.1136/jitc-2021-sitc2021.918 |
Cabanov Alexandra, Spranger Stefani, Gajewski Thomas, Cabanov Alexandra, Torres-Mejia Elen |
| 764161 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
917 Immune landscape at the invasion front of surgically resected oral squamous cell carcinomas shows significant associations with disease specific survival |
2021-11-01 |
10.1136/jitc-2021-sitc2021.917 |
Bouaoud Jebrane, Alvarez Frank Rojas, Michon Lucas, Gadot Nicolas, Lantuejoul Sylvie, Tamegnon Auriole, Jiang Mei, Zhang Shanyu, Renganayaki Pandurengan, Zrounba Philippe, Foy Jean-Philippe, Mahtouk Karène, Bertolus Chloé, Parra Cuentas Edwin Roger, Saintigny Pierre |
| 764160 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
745 Oncolytic adenovirus expressing 4-1BBL demonstrates a significant increase of survival in Diffuse Midline Glioma models |
2021-11-01 |
10.1136/jitc-2021-sitc2021.745 |
Laspidea Virginia, Labiano Sara, Ausejo-Mauleon Iker, Nava Daniel de la, García-Moure Marc, Marco-Sanz Javier, Fueyo Juan, Gomez-Manzano Candelaria, Patiño-García Ana, Alonso Marta |
| 764159 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
703 Favorable pre-clinical safety profile of the novel not-alpha IL-2 agonist ANV419 supports first in human clinical development |
2021-11-01 |
10.1136/jitc-2021-sitc2021.703 |
Huber Christoph, Alonso Guzman, Gerralda Elena, Bucher Christoph, Jacqmin Philippe, Katopodis Andreas, Sims Jennifer |
